Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Division of Hematology, Huashan Hospital of Fudan University, Shanghai 200040, China.
Mol Ther. 2021 May 5;29(5):1918-1932. doi: 10.1016/j.ymthe.2021.01.022. Epub 2021 Jan 21.
Transfusion of red blood cells (RBCs) from ABO-matched but genetically unrelated donors is commonly used for treating anemia and acute blood loss. Increasing demand and insufficient supply for donor RBCs, especially those of universal blood types or free of known and unknown pathogens, has called for ex vivo generation of functional RBCs by large-scale cell culture. However, generating physiological numbers of transfusable cultured RBCs (cRBCs) ex vivo remains challenging, due to our inability to either extensively expand primary RBC precursors (erythroblasts) or achieve efficient enucleation once erythroblasts have been expanded and induced to differentiation and maturation. Here, we report that ectopic expression of the human BMI1 gene confers extensive expansion of human erythroblasts, which can be derived readily from adult peripheral blood mononuclear cells of either healthy donors or sickle cell patients. These extensively expanded erythroblasts (E3s) are able to proliferate exponentially (>1 trillion-fold in 2 months) in a defined culture medium. Expanded E3 cells are karyotypically normal and capable of terminal maturation with approximately 50% enucleation. Additionally, E3-derived cRBCs can circulate in a mouse model following transfusion similar to primary human RBCs. Therefore, we provide a facile approach of generating physiological numbers of human functional erythroblasts ex vivo.
输注 ABO 血型匹配但基因上无关的供者的红细胞 (RBC) 常用于治疗贫血和急性失血。由于对供体 RBC 的需求增加而供应不足,特别是对通用血型或无已知和未知病原体的 RBC 的需求增加,因此需要通过大规模细胞培养来体外生成功能性 RBC。然而,由于我们既不能广泛扩增主要的 RBC 前体(成红细胞),也不能在成红细胞扩增并诱导其分化和成熟后实现有效的去核,因此在体外生成可输血的培养 RBC(cRBC)仍然具有挑战性。在这里,我们报告异位表达人 BMI1 基因赋予了人成红细胞的广泛扩增,这些成红细胞可以很容易地从健康供者或镰状细胞病患者的成人外周血单核细胞中获得。这些广泛扩增的成红细胞 (E3) 能够在定义的培养基中指数级增殖 (>2 个月内 1 万亿倍)。扩增的 E3 细胞具有正常的核型,能够进行终末成熟,去核率约为 50%。此外,E3 衍生的 cRBC 在输血后可在小鼠模型中循环,类似于原发性人 RBC。因此,我们提供了一种简便的方法来在体外生成生理性数量的人功能性成红细胞。